Promoter holding
64.27%
EL
Evertogen Life Sciences Limited - Due diligence report
A 360° intelligence report on Evertogen: trust score, financial health, credit view, compliance, directors, growth and distress signals - ge…
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Evertogen — 360° Intelligence Report
Generated from MCA filings & public records62/100
Trust Score
Moderate
Evertogen is assessed as Moderate with a Trust Score of 62/100. Evertogen is an active public limited indian non-government company incorporated in 2013, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and high financial risk profile.
Report generated on 15 Oct 2026 from the latest processed filings. Evertogen Life Sciences Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreModerate
62/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
61/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
20/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
45/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
65/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
60/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Standalone · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 45/100 Caution Indicated
- Negative operating earnings - debt service depends on external support.
- Externally credit-rated (D).
Charges position: 4 open (135.17 cr) · 3 satisfied (36.51 cr).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| Axis Bank Limited | 2 | 48.0 cr |
| Hdfc Bank Limited | 1 | 48.0 cr |
| Others | 3 | 48.0 cr |
| Tata Capital Financial Services Limited | 1 | 48.0 cr |
Compliance Score: 61/100 Moderate
- Company status is Active as per MCA.
- Last balance sheet is for Mar 2024 - filings overdue.
- Litigation present in 2 court forum(s).
- 3 active GST registration(s).
Legal cases on record (2)
05
Director Intelligence
Stability score: 95/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| MANAV JASSAL | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SUBBARAO KATTAMURI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SHERIFUDDIN SHERIFF SHAIK | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| VIKRAM RAVINDRA MAMIDIPUDI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SUSHMA KATTAMURI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SAT PAUL JASSAL | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Akhila Thotapally | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 7 directors on the board.
- No disqualified or deactivated DINs.
- Stable board - no exits in 3 years.
- Average tenure above 5 years.
Director & KMP remuneration (FY 2023)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2023 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
Glochem Industries Private Limited
Subsidiaries
-
Group entities
1
Capital events
31 allotment(s) · 0 transfer(s)
Promoters hold a dominant controlling stake - exact percentages are part of the full report.
| Group entity | Relationship | % held |
|---|---|---|
| Glochem Industries Private Limited | Holding Company | 74.00% |
| Organosyn Life Sciences Private Limited | Associate Company | 74.00% |
Key managerial personnel: SUBBARAO KATTAMURI (Managing Director)
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 65 · Distress 60
Growth signals & trust indicators
Latest year revenue grew 38%.
EPFO headcount growing - hiring signal.
Operating for 13+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Negative net worth.
Statutory filings appear overdue.
4 open charge(s) registered - assets are encumbered.
2 court case(s) on record - see the legal section for details.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence61/100
Review suggested
Suitability as a supplier / customer counterparty.
- Check the compliance flags before onboarding.
- 2 distress signal(s) - see Risk Center.
- Financial filings available for verification.
Banker assessment42/100
Enhanced diligence advised
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- 4 open charge(s) of 135.17 cr already registered.
- Compliance gaps should be priced into terms.
Investor view48/100
Mixed indicators
Growth quality and scalability through an investor lens.
- 2 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management team looks stable.
09
MCA Filings & Events Timeline
Latest 15 events22 Jul 2025
Director appointed
Akhila Thotapally (Company Secretary)
01 Oct 2024
Charge satisfied
Others
09 Sep 2024
Last AGM held
Annual general meeting
31 Mar 2024
Latest balance sheet
Filed with ROC
06 Dec 2023
Director appointed
SHERIFUDDIN SHERIFF SHAIK (Director)
23 Sep 2022
Director ceased
ASHOK REDDY BODANAPU
14 Jul 2022
Charge satisfied
Others
18 Apr 2022
Charge created
Hdfc Bank Limited - 37.30 cr
31 Mar 2022
Director ceased
KALYAN NAGURURU
29 Mar 2022
Charge created
Others - 20.00 cr
25 Mar 2022
Securities allotted
3000000 Debentures - 3.00 cr raised
23 Mar 2022
Director ceased
Asfia Moin
05 Jan 2022
Securities allotted
22761347 Equity Shares - 22.76 cr raised
Director appointed
SUSHMA KATTAMURI (Director)
14 Sep 2021
Director ceased
SAT PAUL JASSAL
10
Key Observations
Auto-generated from the data aboveRevenue grew 1.42 over the last 4 financial year(s).
Net profit margin moved from 2.1x to 24%.
7 active director(s) / partner(s); board looks stable and experienced.
3 active GST registration(s) indicate ongoing business operations.
Carries an external credit rating of D from Crisil.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 31 security allotment(s) - amounts available in the full report.
| Company | CIN | Location |
|---|---|---|
| Abel Chemicals Pvt Ltd | U24110TG1989PTC009779 | Rangareddy, Telangana |
| Raplap Private Limited | U52609TG2020PTC138925 | Hyderabad, Telangana |
| Zobkar Infotech Private Limited | U72200TG2009PTC066125 | Hyderabad, Telangana |
| Swarnasree Finance And Leasing Pvt Ltd | U65910AP1993PTC016487 | Rangareddy, Telangana |
| Softbharat Solutions Private Limited | U72200TG2015PTC097138 | Rangareddy, Telangana |
| Reddy Investments Pvt. Ltd. | U65993TG1991PTC012261 | Hyderabad, Telangana |
| Juizy Krackers Private Limited | U56102TS2023PTC176715 | Rangareddy, Telangana |
| Srishantidweepa Consultancy Private Limited | U70109TG2021PTC147827 | Rangareddy, Telangana |
| Shri Vasavimatha Builders & Developers Private Limited | U70102TG2008PTC061727 | Hyderabad, Telangana |
| Jahangeer Khan Fleet Services Private Limited | U63090TG2017PTC119158 | Rangareddy, Telangana |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Evertogen before audits and certifications: compliance score 61/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Evertogen: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Enhanced diligence advised. Credit risk score 45/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Mixed indicators. Growth score 65/100, margin trends, ownership structure and peer set for Evertogen - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Review suggested. Trust score 62/100, distress signals and MSME payment-delay disclosures - know whether Evertogen pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (2 case(s) on record), regulatory flags, charge documents trail and director networks for Evertogen - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Evertogen an active company?
Evertogen has MCA status “Active” with a compliance score of 61/100 (Moderate).
Is Evertogen financially healthy?
Evertogen has a Financial Health Score of 20/100 (Caution Indicated) based on its filed financial statements.
Should I do business with Evertogen?
Its overall Trust Score is 62/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Evertogen?
The ultimate holding entity is Glochem Industries Private Limited. 7 active director(s) are on record.
Does Evertogen have loans or charges against its assets?
4 open charge(s) are registered against its assets, and 3 earlier charge(s) stand satisfied.
Is Evertogen up to date with its ROC filings?
Last balance sheet is for Mar 2024 - filings overdue. Overall compliance score: 61/100 (Moderate).
Is it risky to lend to Evertogen?
Its Credit Risk Score is 45/100 (Caution Indicated). Banker verdict: Enhanced diligence advised.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
